News Buzz: Celldex Therapeutics, salesforce.com, Boulder Brands, Velti

Lakeway, NY -- (SBWIRE) -- 03/04/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares increased 7.77% and closed at $10.26 in yesterday’s session. The company will release fourth quarter and year end 2012 financial results on Thursday, March 7, 2013 before the U.S. financial markets open. Celldex executives will host a conference call at 8:30 a.m. ET on the same day to discuss 2012 financial and business results and to provide an update on key 2013 objectives.

Aditionally, CLDX’s stock had its price target raised by Oppenheimer from $10.00 to $13.00 in a research report released on Feb. 26. Oppenheimer currently has an outperform rating on the stock.

Is CLDX a Still a Buy after the Solid momentum? Let’s Find out Here

salesforce.com, inc. (NYSE:CRM) stock jumped 7.55% to $182. For the quarter ended Jan. 31, the company reported a loss of $20.8 million, or 14 cents a share, compared with a year-earlier loss of $4.1 million, or three cents a share. Adjusted earnings rose to 51 cents from 43 cents. Revenue jumped 32% to $834.7 million. The company in November gave a cautious view of per-share earnings of 38 cents to 40 cents on revenue of $825 million to $830 million.

Is CRM a Strong Buying Opportunity After The Recent Slump? Find out Here

Boulder Brands Inc (NASDAQ:BDBD) shares jumped 7.16% to $9.13. The company, on Feb. 28, announced its financial results for the fourth quarter ended December 31, 2012. For the fourth quarter of 2012 compared to the equivalent period of 2011, net sales increased 34.7% to $113.0 million, GAAP operating income increased 70.4% to $11.2 million, and cash operating income increased 64.6% to $18.6 million. GAAP earnings per share were $0.06 in the fourth quarter of 2012, compared to $0.03 per share in the fourth quarter of 2011.

Should BDBD Buy BDBD After The Recent Movement? Let’s Find out Here

Velti Plc (NASDAQ:VELT) shares jumped 7.07% and closed at $3.94 in the last trading session. VELT’s stock was downgraded by equities researchers at Craig Hallum from a “buy” rating to a “hold” rating in a report issued on Jan. 31. They currently have a $4.00 target price on the stock, down from their previous target price of $12.00. The company is a global provider of mobile marketing and advertising technology and solutions.

Is VELT a Strong Buying Opportunity After The Recent Slump? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.